Café

© 2026 Longbridge｜Terms of Service Privacy Policy

CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial | CERO Stock News

CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial | CERO Stock News

StockTitan

May 10, 2026 at 11:15 PM

CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial | CERO Stock News

CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial | CERO Stock News

Login to unlock101characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

CERo Therapeutics

USCERO

-4.00%

CERO THERAPEUTICS HOLDINGS INC C/WTS 14/02/2029 (TO PUR COM)

USCEROW

VanEck Biotech ETF

USBBH

LongbridgeAI